Registration number: 12329276

Micrographia Bio Limited

Contents

Company Information	1
Balance Sheet	2
Notes to the Unaudited Financial Statements	3 to 7

Micrographia Bio Limited

Company Information

Directors

Ms Julia Li Mr Christopher Thompson

Registered office

Dawes Road Hub 20 Dawes Road London SW6 7EN

Micrographia Bio Limited

(Registration number: 12329276)
Balance Sheet as at 30 November 2024

	Note	2024 £	2023 £
Fixed assets
Intangible assets	5	213,301	181,140
Tangible assets	6	56,665	85,266
		269,966	266,406
Current assets
Debtors	7	720,541	266,308
Cash at bank and in hand		2,550,468	3,703,058
		3,271,009	3,969,366
Creditors: Amounts falling due within one year	8	(95,613)	(100,598)
Net current assets		3,175,396	3,868,768
Net assets		3,445,362	4,135,174
Capital and reserves
Called up share capital		155	155
Share premium reserve		6,654,564	6,654,564
Retained earnings		(3,209,357)	(2,519,545)
Shareholders' funds		3,445,362	4,135,174

For the financial year ending 30 November 2024 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

•	The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
•	The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 9 September 2025 and signed on its behalf by:
 

......................................... Ms Julia Li Director

Micrographia Bio Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2024

1	General information

The company is a private company limited by share capital, incorporated in England.

The address of its registered office is:
Dawes Road Hub
20 Dawes Road
London
SW6 7EN
England

2	Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Foreign currency transactions and balances

Transactions in foreign currencies are initially recorded at the functional currency rate prevailing at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are retranslated into the respective functional currency of the entity at the rates prevailing on the reporting period date. Non-monetary items carried at fair value that are denominated in foreign currencies are retranslated at the rate on the date when the fair value is re-measured.

Non-monetary items measured in terms of historical cost in a foreign currency are not retranslated.

Tax

The tax expense for the period comprises current tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Micrographia Bio Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2024

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class	Depreciation method and rate
Office equipment	25% straight line

Intangible assets

Separately acquired trademarks and licences are shown at historical cost.

Trademarks, licences (including software) and customer-related intangible assets acquired in a business combination are recognised at fair value at the acquisition date.

Trademarks, licences and customer-related intangible assets have a finite useful life and are carried at cost less accumulated amortisation and any accumulated impairment losses.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class	Amortisation method and rate
Intangible assets	10% straight line

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Debtors receivable within one year
Debtors with no stated interest rate and receivable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.
 

Micrographia Bio Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2024

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

Creditors payable within one year
Creditors with no stated interest rate and payable within one year are recorded at transaction price. Any losses arising from impairment are recognised in the profit and loss account in other administrative expenses.
 

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3	Staff numbers

The average number of persons employed by the company (including directors) during the year, was 13 (2023 - 13).

4

Taxation

Tax charged/(credited) in the income statement

	2024  £	2023  £
Current taxation
UK corporation tax	(773,774)	-
Deferred taxation
Arising from origination and reversal of timing differences	-	(11,616)
Tax receipt in the income statement	(773,774)	(11,616)

Micrographia Bio Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2024

5	Intangible assets

	Trademarks, patents and licenses  £	Total £
Cost or valuation
At 1 December 2023	181,140	181,140
Additions acquired separately	32,161	32,161
At 30 November 2024	213,301	213,301
Amortisation
Carrying amount
At 30 November 2024	213,301	213,301
At 30 November 2023	181,140	181,140

6	Tangible assets

	Office equipment £	Total £
Cost or valuation
At 1 December 2023	126,330	126,330
Additions	3,081	3,081
At 30 November 2024	129,411	129,411
Depreciation
At 1 December 2023	41,064	41,064
Charge for the year	31,682	31,682
At 30 November 2024	72,746	72,746
Carrying amount
At 30 November 2024	56,665	56,665
At 30 November 2023	85,266	85,266

7

Debtors

	2024 £	2023 £
Prepayments	31,388	31,180
Other debtors	689,153	235,128
	720,541	266,308

Micrographia Bio Limited

Notes to the Unaudited Financial Statements for the Year Ended 30 November 2024

8

Creditors

Creditors: amounts falling due within one year

	2024 £	2023 £
Due within one year
Trade creditors	28,607	91,487
Taxation and social security	31,136	-
Accruals and deferred income	13,032	1,587
Other creditors	22,838	7,524
	95,613	100,598

9	Share capital

Allotted, called up and fully paid shares

	2024		2023
	No.	£	No.	£
Ordinary shares of £0.0001 each	977,239	98	977,239	98
Ordinary B shares of £0.0001 each	817	-	817	-
Series seed 1 convertible preferred shares of £0.0001 each	312,952	31	312,952	31
Series seed 2 convertible preferred shares of £0.0001 each	64,677	6	64,677	6
Series seed 3 convertible preferred shares of £0.0001 each	193,184	19	193,184	19
	1,548,869	155	1,548,869	155